Aerosol formulations suitable for use in pressurised metered dose inhalers
comprise a hydrofluoroalkane propellant, an medicament for inhalation and a surfactant
which is a a C8-C16 fatty acid or salt thereof, a bile salt,
a phospholipid, or an alkyl saccharide.
